Answers are grounded in this paper and cite their sources.
Aims: Diabetes mellitus (DM) (Ziabetus Shakri) is a common metabolic disease affecting 150,000,000 people worldwide. Despite the recent advancements in management of Diabetes its relative co-morbidities and mortality is ever increasing globally. Unani scholars had claimed the effectiveness of several anti-diabetic drugs in the classical texts in the management of DM, but it lacks scientific documentation. Hence, a clinical trial was contemplated to evaluate the efficacy of test drug Tahlab (Spirulina) in patients of type 2 DM.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: